Veracyte (VCYT) Stock Insights

VCYT price $50.31 +0.03 +0.06%

Ticker
VCYT
Price
$50.31
Change
+0.03 +0.06%
Market cap ?
$4.04B
P/E ?
34.92
Forward P/E ?
26.35
Dividend yield ?
0.00%
Beta ?
1.95
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Stocklytics score
65
Value
44
Quality
79
Growth
71

Stocklytics score rationale: value 44, quality 79, growth 71.

Financials

2016201720182019202020212022202320242025
650850007195300092008000120368000117483000219514000296536000361051000445764000517145000

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer…

Fair value

VCYT fair value $57.27. Price $50.31. Price is 12% below fair value.

Above fair value, but less expensive than usual. A smaller premium than on 80% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 74.90M. Growth 14.59%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 1.9). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 80.39M. Net debt -322.92M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare VCYT

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—0.41—147.16M
2026-07-300.540.41150.32M144.59M
2026-05-050.520.34139.07M130.36M
2026-02-250.530.41140.64M135.79M
2025-11-040.510.32131.87M124.97M
2025-08-060.440.31130.20M121.04M
2025-05-070.310.12114.50M111.27M
2025-02-240.070.10118.63M116.70M
2024-11-060.190.03115.86M109.82M
2024-08-060.07-0.03114.40M100.27M
2024-05-07-0.02-0.1696.84M93.35M
2024-02-22-0.39-0.0798.20M91.97M
2023-11-07-0.41-0.1690.11M84.36M
2023-08-08-0.12-0.1590.32M83.05M
2023-05-04-0.11-0.1382.42M75.80M
2023-02-22-0.05-0.1580.30M73.94M
2022-11-02-0.12-0.2575.59M66.41M
2022-08-02-0.13-0.2272.90M68.08M
2022-05-03-0.20-0.2467.78M61.92M
2022-02-28-0.15-0.1667.34M62.52M
2021-11-09-0.13-0.1460.37M53.64M
2021-07-29-0.13-0.2555.10M55.10M
2021-05-10-0.11-0.1236.70M32.03M
2021-02-17-0.14-0.1134.54M31.75M
2020-11-02-0.08-0.2131.12M81.69M
2020-07-30-0.22-0.2420.70M22.59M
2020-05-06-0.24-0.2031.12M25.93M
2020-02-25-0.15-0.0729.73M23.65M
2019-10-22-0.02-0.0730.97M108.41M
2019-07-30-0.05-0.1030.14M60.27M
2019-04-30-0.05-0.1029.53M59.06M
2019-02-25-0.08-0.1525.75M48.28M
2018-10-29-0.12-0.2423.47M46.93M
2018-07-23-0.18-0.2722.75M34.13M
2018-05-01-0.27-0.2520.04M18.56M
2018-02-27-0.24-0.2019.60M16.33M
2017-11-06-0.21-0.2317.52M19.19M
2017-07-31-0.22-0.2518.41M20.92M
2017-05-03-0.24-0.2516.43M17.12M
2017-03-01-0.14-0.2618.26M33.91M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-19Bhanji MunaSell1.86K$43.7081.46K
2026-09-21Leite JohnSell4.01K$40.00160.60K
2026-09-14Holstein JensSell5.00K$40.95204.75K
2026-09-04Febbo Phillip G.Sell10.40K$42.89446.30K
2026-09-04Febbo Phillip G.Sell2.71K$43.66118.11K
2026-09-04Chambers RebeccaSell2.48K$42.81106.03K
2026-09-04Chambers RebeccaSell1.18K$43.7151.36K
2026-09-04McGuire AnnieSell2.15K$42.7992.17K
2026-09-04McGuire AnnieSell1.10K$43.6748.04K
2026-09-02Wygant JonathanSell1.36K$44.8861.08K
2026-09-02Leite JohnSell3.96K$44.88177.77K
2026-09-02Febbo Phillip G.Sell3.64K$44.88163.32K
2026-09-02Chambers RebeccaSell3.60K$44.88161.70K
2026-09-02McGuire AnnieSell3.21K$44.88144.29K
2026-09-02Stapley MarcSell8.78K$44.88394.14K
2026-09-01Bhanji MunaSell1.86K$42.9780.10K
2026-06-18EASTHAM KARINSell3.20K$52.78168.91K
2026-06-18EASTHAM KARINSell529$53.5528.33K
2026-06-11EASTHAM KARINBuy5.27K——
2026-06-11JONES EVAN/ FABuy5.27K——
2026-06-11Shafer David BrentBuy5.27K——
2026-06-11Barr EliavBuy5.27K——
2026-06-11EPSTEIN ROBERT SBuy5.27K——
2026-06-11Holstein JensBuy5.27K——
2026-06-11Bhanji MunaBuy5.27K——
2026-06-11Miller Thomas F.Buy5.27K——
2026-06-04McGuire AnnieSell1.40K$49.3169.03K
2026-06-04McGuire AnnieSell1.78K$50.1289.01K
2026-06-04Chambers RebeccaSell1.60K$49.2878.85K
2026-06-04Chambers RebeccaSell1.96K$50.0998.23K
2026-06-04Stapley MarcBuy138.05K$36.605.05M
2026-06-04Stapley MarcSell138.05K$50.126.92M
2026-06-04Stapley MarcSell138.05K$36.605.05M
2026-06-04Leite JohnSell13.97K$50.07699.73K
2026-06-02McGuire AnnieSell3.29K$47.80157.36K
2026-06-02Wygant JonathanSell1.36K$47.8065.06K
2026-06-02Chambers RebeccaSell3.69K$47.80176.53K
2026-06-02Febbo Phillip G.Sell3.73K$47.80178.29K
2026-06-02Stapley MarcSell9.01K$47.80430.77K
2026-06-02Leite JohnSell4.06K$47.80194.02K
2026-05-22Wygant JonathanBuy24.00K$24.80595.20K
2026-05-22Wygant JonathanSell24.00K$45.401.09M
2026-05-22Wygant JonathanSell24.00K$24.80595.20K
2026-05-20EPSTEIN ROBERT SSell10.00K$44.01440.13K
2026-05-06McGuire AnnieSell5.10K$38.05194.13K
2026-05-06McGuire AnnieSell5.10K$40.00204.08K
2026-04-10Haas Kevin RichardBuy44.22K——
2026-03-24Haas Kevin RichardOther0——
2026-03-06Wygant JonathanBuy10.53K——
2026-03-06McGuire AnnieBuy26.31K——
2026-03-06McGuire AnnieBuy32.89K——
2026-03-06Febbo Phillip G.Buy6.58K——
2026-03-06Febbo Phillip G.Buy29.60K——
2026-03-06Leite JohnBuy6.58K——
2026-03-06Leite JohnBuy36.18K——
2026-03-06Stapley MarcBuy92.10K——
2026-03-06Chambers RebeccaBuy13.16K——
2026-03-06Chambers RebeccaBuy36.18K——
2026-03-04Chambers RebeccaSell4.40K$35.55156.41K
2026-03-04Chambers RebeccaSell13.94K$36.33506.46K
2026-03-04Stapley MarcSell19.24K$35.56684.23K
2026-03-04Stapley MarcSell26.28K$36.28953.37K
2026-03-04Leite JohnSell5.26K$35.19185.08K
2026-03-04McGuire AnnieSell4.99K$35.29176.26K
2026-03-04McGuire AnnieSell1.66K$36.3460.47K
2026-03-02McGuire AnnieSell6.90K$36.01248.54K
2026-03-02Wygant JonathanSell3.01K$36.01108.25K
2026-03-02Chambers RebeccaSell7.23K$36.01260.50K
2026-03-02Leite JohnSell7.52K$36.01270.69K
2026-03-02Febbo Phillip G.Sell6.04K$36.01217.32K
2026-03-02Febbo Phillip G.Sell13.43K$36.16485.43K
2026-03-02Stapley MarcSell19.45K$36.01700.57K
2026-02-26Leite JohnBuy47.15K——
2026-02-26Leite JohnSell8.90K$38.75345.07K
2026-02-26Stapley MarcBuy139.07K——
2026-02-26Stapley MarcSell35.84K$38.751.39M
2026-02-26Chambers RebeccaBuy59.32K——
2026-02-26Chambers RebeccaSell12.05K$38.75466.90K
2026-02-26Febbo Phillip G.Buy71.81K——
2026-02-26Febbo Phillip G.Sell24.49K$38.75948.83K
2026-02-26McGuire AnnieBuy51.00K——
2026-02-26McGuire AnnieSell10.87K$38.75421.10K
2025-12-16McGuire AnnieSell10.64K$43.13458.84K
2025-12-16McGuire AnnieSell100$43.684.37K
2025-12-05EASTHAM KARINBuy10.00K$7.6076.00K
2025-12-05EASTHAM KARINSell6.39K$44.52284.57K
2025-12-05EASTHAM KARINBuy10.00K$7.9479.40K
2025-12-05EASTHAM KARINSell12.81K$45.84587.08K
2025-12-05EASTHAM KARINSell800$46.5937.27K
2025-12-05EASTHAM KARINSell10.00K$7.9479.40K
2025-12-05EASTHAM KARINSell10.00K$7.6076.00K
2025-12-04McGuire AnnieSell720$47.1033.91K
2025-12-04McGuire AnnieSell702$47.5133.35K
2025-12-04Chambers RebeccaSell8.54K$46.61397.95K
2025-12-04Chambers RebeccaSell4.74K$47.25224.01K
2025-12-04Stapley MarcSell4.45K$46.90208.61K
2025-12-04Stapley MarcSell3.22K$47.35152.46K
2025-12-04Leite JohnSell1.28K$47.5160.72K
2025-12-02Febbo Phillip G.Sell2.96K$46.16136.40K
2025-12-02McGuire AnnieSell3.05K$46.16140.88K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 379, holders +39 vs prior quarter. Ownership 113.09%.

HolderSharesChangeChange %Value
BLACKROCK, INC.13.49M313.82K+2.38%792.06M
FMR LLC7.70M-61.10K-0.79%452.38M
ARTISAN PARTNERS LIMITED PARTNERSHIP5.54M42.03K+0.76%325.27M
VANGUARD PORTFOLIO MANAGEMENT LLC4.72M271.46K+6.11%276.98M
STATE STREET CORP4.70M-345.46K-6.85%275.95M
VANGUARD CAPITAL MANAGEMENT LLC3.59M61.69K+1.75%211.07M
DIMENSIONAL FUND ADVISORS LP2.83M-54.57K-1.89%166.01M
FIRST TRUST ADVISORS LP2.51M390.86K+18.46%147.29M
ARK INVESTMENT MANAGEMENT LLC2.30M-757.87K-24.82%134.84M
WELLINGTON MANAGEMENT GROUP LLP2.27M-284.12K-11.11%133.56M
GEODE CAPITAL MANAGEMENT, LLC2.10M146.90K+7.51%123.59M
GOLDMAN SACHS GROUP INC1.64M366.65K+28.73%96.49M
FULLER & THALER ASSET MANAGEMENT, INC.1.51M95.39K+6.74%88.67M
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC1.43M441.91K+44.65%84.08M
GW&K INVESTMENT MANAGEMENT, LLC1.42M-20.78K-1.45%83.19M
MORGAN STANLEY1.19M393.99K+49.38%69.99M
BANK OF AMERICA CORP /DE/1.10M-346.62K-23.92%64.74M
DRIEHAUS CAPITAL MANAGEMENT LLC1.05M1.05MNew61.42M
NORTHERN TRUST CORP996.15K66.65K+7.17%58.50M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.939.98K939.98KNew55.21M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC939.98K16.41K+1.78%55.21M
OBERWEIS ASSET MANAGEMENT INC/877.73K37.90K+4.51%51.55M
LEGAL & GENERAL GROUP PLC858.14K-39.03K-4.35%50.40M
SUMITOMO MITSUI TRUST GROUP, INC.768.95K-286.71K-27.16%45.16M
AMOVA ASSET MANAGEMENT AMERICAS, INC.768.95K-276.10K-26.42%45.12M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Veracyte (VCYT) Stock Insights

VCYT$50.31+0.03 +0.06%

$4.04B

Market Cap

34.92

P/E

26.35

Forward P/E

65

Score

Price History